Search
for
Sort by
Research 211–240 of 1000+
- Beyond Minoxidil: Off-Label Therapies for Male Androgenetic Alopecia—A Systematic Review with Network Meta-Analyses
- Hormonal Treatment of Transgender Women with Oral Estradiol
- Dermatological considerations for transgender and gender diverse patients: An Australian perspective
- Androgenetik Alopesi
- Addressing Androgenetic Alopecia-A Complex Disorder-with a Multilateral Treatment Strategy
- Dermatologic care for lesbian, gay, bisexual, and transgender persons
- Role and Mechanisms of Phytochemicals in Hair Growth and Health
- 26-SNP Panel Aids Guiding Androgenetic Alopecia Therapy and Provides Insight into Mechanisms of Action
- Recent Advances in Drug Development for Hair Loss
- Idiopathic Alopecia—A Retrospective Descriptive Study Integrated with the Current Literature
- Dysregulation of Leukaemia Inhibitory Factor (LIF) Signalling Pathway by Supraphysiological Dose of Testosterone in Female Sprague Dawley Rats During Development of Endometrial Receptivity
- The Hormonal Background of Hair Loss in Non-Scarring Alopecias
- The Possible Role of Prescribing Medications, Including Central Nervous System Drugs, in Contributing to Male-Factor Infertility (MFI): Assessment of the Food and Drug Administration (FDA) Pharmacovigilance Database
- Bioactive Compound-Loaded Nanocarriers for Hair Growth Promotion: Current Status and Future Perspectives
- FINASTERIDE FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
- Gender‐affirming hormone therapy for transgender and gender‐diverse adults in Australia
- Status of research on the development and regeneration of hair follicles
- Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs
- Current understanding and treatment of sex hormone-related hair diseases
- Weekly treatment with SAMiRNA targeting the androgen receptor ameliorates androgenetic alopecia
- Physicochemical Characterization of Chitosan-Decorated Finasteride Solid Lipid Nanoparticles for Skin Drug Delivery
- Efficacy and safety of topical finasteride spray solution in the treatment of Chinese men with androgenetic alopecia: A phase III, multicenter, randomized, double-blind, placebo-controlled study
- Oral Finasteride (5 mg and 2 mg) versus Topical Minoxidil 5% in Female Pattern Hair Loss
- The Molecular Mechanism of Natural Products Activating Wnt/β-Catenin Signaling Pathway for Improving Hair Loss
- Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study
- The state‐of‐the‐art in the management of androgenetic alopecia: A review of new therapies and treatment algorithms
- Effectiveness of Combined Oral Minoxidil and Finasteride in Male Androgenetic Alopecia: A Retrospective Service Evaluation
- Efficacy of the association of topical minoxidil and topical finasteride compared to their use in monotherapy in men with androgenetic alopecia: A prospective, randomized, controlled, assessor blinded, 3‐arm, pilot trial
- Medical and procedural treatment of androgenetic alopecia – Where are we?
- Comparative efficacy of topical finasteride (0.25%) in combination with minoxidil (5%) against 5% minoxidil or 0.25% finasteride alone in male androgenetic alopecia: A pilot, randomized open-label study